Lanadelumab for Monoclonal Gammopathy of Angioedema-Associated Significance in Acquired C1-Esterase Inhibitor Deficiency: A Case Series
Publication date
2026
Authors
de Jong, G. M.
Bulatović-Ćalasan, M.
Heijstek, M. W.
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Keywords
Angioedema due to acquired C1-inhibitor deficiency, Lanadelumab, Monoclonal gammopathy of angioedema-associated significance, Immunology and Allergy, Immunology
Citation
de Jong, G M, Bulatović-Ćalasan, M & Heijstek, M W 2026, 'Lanadelumab for Monoclonal Gammopathy of Angioedema-Associated Significance in Acquired C1-Esterase Inhibitor Deficiency : A Case Series', Journal of Investigational Allergology and Clinical Immunology, vol. 36, no. 3, pp. 252-254. https://doi.org/10.18176/jiaci.1152